Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ- but not ε-opioid receptor agonist in the mouse

Neuroscience

Volumn 76, Issue 1, 1996, Pages 291-298

  Narita, M ^a   Ohsawa, M ^b   Mizoguchi, H ^a   Kamei, J ^b   Tseng, L F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

antinociception; desensitization; phorbol ester; protein kinase C; tolerance; opioid receptor and opioid receptor

Indexed keywords

BETA ENDORPHIN; CALPHOSTIN C; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; OPIATE AGONIST; OPIATE RECEPTOR; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

EID: 0030571569     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00354-5     Document Type: Article

References (38)

1. Chen Y., Mestek A., Liu J., Hurley J., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Molec. Pharmac. 44:1993;8-12.
2. Chung K. M., Song D. K., Suh H. W., Lee M. H., Kim Y. H. Effects of intrathecal or intracerebroventricular pretreatment with pertussis toxin on antinociception induced by β-endorphin or morphine administered intracerebroventricularly in mice. Naunyn-Schmiedeberg's Arch. Pharmac. 349:1994;588-593.
3. D'Amour F. E., Smith D. L. A method for determining loss of pain sensation. J. Pharmac. exp. Ther. 72:1941;74-79.
4. Evans C., Keith D., Morrison H., Magendzo K., Edwards R. Cloning of a delta receptor by functional expression. Science. 258:1992;1952-1955.
5. Feldberg W., Smyth D. G. The C-fragment of lipotropin: an endogenous potent analgesic peptides. Br. J. Pharmac. 60:1977;445-453.
6. Haley M. J., McCormick W. G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mice. Br. J. Pharmac. 12:1957;12-15.
7. Hosobuchi Y., Li C. H. The analgesic activity of human β-endorphin in man. Commun. Psychopharmac. 2:1978;33-37.
8. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252a compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinase. Biochem. biophys. Res. Commun. 142:1987;436-440.
9. Kieffer B. L., Befort K., Gaveriaux-Ruff C., Hirth C. G. The delta-opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proc. natn. Acad. Sci. U.S.A. 89:1992;12048-12052.
10. Kikkawa U., Takai Y., Minakuchi R., Inohara S., Nishizuka Y. Calcium-activated, phospholipid-dependent protein kinase from rat brain. J. biol. Chem. 257:1982;13341-13348.
11. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. biophys. Res. Commun. 159:1989;548-553.
12. Liang Y., Mestek A., Yu L., Carr L. G. Cloning and characterization of the promoter region of the mouse μ-opioid receptor gene. Brain Res. 679:1995;82-88.
13. Loh H. H., Tseng L. F., Wei E., Li C. J. β-endorphin is a potent analgesic agent. Proc. natn. Acad. Sci. U.S.A. 73:1976;2895-2898.
14. Mangoura D., Dawson G. Opioid peptides activate phospholipase D and protein kinase C-ε in chicken embryo neuron cultures. Proc. natn. Acad. Sci. U.S.A. 90:1993;2915-2919.
15. Meglio M., Hosobuchi Y., Loh H. H., Adams J. E., Li C. H. β-endorphin: behavioral and analgesic activity in cats. Proc. natn. Acad. Sci. U.S.A. 74:1977;774-776.
16. Miotto K., Magendzo K. and Evans C. J. (1995) Molecular characterization of opioid receptors. In The Pharmacology of Opioid Peptides (ed. Tseng L. F.), pp. 57-71, Harwood Academic Publishers, Switzerland.
17. Narita M., Feng Y. -Z., Makimura M., Hoskins B., Ho I. K. A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur. J. Pharmac. 271:1994;543-545.
18. Narita M., Feng Y. -Z., Makimura M., Hoskins B., Ho I. K. Repeated administration of opioids alters characteristics of membrane-bound phorbol ester binding in rat brain. Eur. J. Pharmac. 271:1994;547-550.
19. Narita M., Makimura M., Feng Y. -Z., Hoskins B., Ho I. K. Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res. 650:1994;175-179.
20. Narita M., Narita M., Mizoguchi H., Tseng L. F. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered μ-opioid receptor agonist in the mouse. Eur. J. Pharmac. 280:1995;R1-R3.
21. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 233:1986;305-312.
22. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 334:1988;661-665.
23. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
24. Nock B. (1995) κ- and ε-opioid receptor binding. In The Pharmacology of Opioid Peptides (ed. Tseng L. F.), pp. 29-56, Harwood Academic Publishers, Switzerland.
25. Nock B., Giordano A. L., Moore B. W., Cicero T. J. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain. J. Pharmac. exp. Ther. 264:1993;349-359.
26. Pei G., Kieffer B. L., Lefkowitz R. J., Freedman N. J. Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Molec. Pharmac. 48:1995;173-177.
27. Sadëe W., Wang Z., Arden J. R., Segredo V. Constitutive activation of the μ-opioid receptor: a novel paradigm of the receptor regulation in narcotic analgesia, tolerance and dependence. Analgesia. 1:1994;11-14.
28. Shearman M. S., Sekiguchi K., Nishizuka Y. Modulation of ion channel activity: a key function of the protein kinase C enzyme family. Pharmac. Rev. 41:1989;211-237.
29. Smart D., Smith G., Lambert D. G. μ-opioid receptor stimulation of inositol (1,4,5) trisphosphate formation via a pertussis toxin-sensitive G protein. J. Neurochem. 62:1994;1009-1014.
30. 5-enkephalin- and U50,488H-induced analgesia in mice. Neuropharmacology. 27:1988;957-963.
31. Tallarida R. J. and Murray R. B. (1987) Manual of Pharmacological Calculation with Computer Programs, Springer, New York.
32. Tseng L. F. (1995) Mechanisms of β-endorphin-induced antinociception. In The Pharmacology of Opioid Peptides (ed. Tseng L.F.), pp. 249-269. Harwood Academic Publishers, Switzerland.
33. Tseng L. F., Collins K. A. Spinal involvement of both dynorphin A and metenkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse. J. Pharmac. exp. Ther. 266:1993;1430-1438.
34. Tseng L. F. and Collins K. A. (1995) Pretreatment with pertussis toxin blocks morphine- but not β-endorphin-induced antinociception in the mouse, Eur. J. Pharmac., in press.
35. 5]-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats. Brain Res. 343:1985;60-69.
36. 5]-enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice. Eur. J. Pharmac. 173:1989;171-176.
37. Yasuda K., Raynor K., Kong H., Breder C., Takeda J., Reisine T., Bell G. I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. natn. Acad. Sci. U.S.A. 90:1993;6736-6740.
38. Zimmermann M. Ethical guidelines for investigators of experimental pain in conscience animals. Pain. 16:1983;109-110.